Skip to content
Open in App
Adocia logo

Adocia

web2

Adocia is a French biotechnology company developing drug delivery technologies and therapeutic...

Symbol ยท ADOC
Company profile

About

Adocia is a French biotechnology company developing drug delivery technologies and therapeutic candidates for diabetes and obesity, with a focus on insulin and peptide formulations. Its BioChaperone platform supports the formulation and delivery of therapeutic proteins, including insulin combinations and treatments involving metabolic hormones. Other development platforms include AdoShell for cell therapy, AdoOral for oral peptide delivery, and AdoXLong for longer acting injectable formulations. Adocia advances research programs through preclinical development and clinical studies, depending on the candidate. Its business model involves establishing technical or clinical evidence before licensing products and technology platforms to pharmaceutical partners for further development and potential commercialization.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

ExchangeParisPrimary symbol: ADOC
Expert coverage

Adocia profile.

Orbitrum research

Expert coverage

No published expert evaluations are available for this project yet.

Orbitrum Academy

Learn how to read a project assessment